Call Us Today:
949.200.1600

SCC Keratoacanthoma Type

Home > Diagnosis > Squamous Cell Carcinoma > SCC Keratoacanthoma Type

Skin-Cancer-Specialists-Squamous-Cell-Carcinoma-Keratoacanthoma-Skin-Cancer-And-Reconstructive-Surgey-Center-Orange-County

About SCC Keratoacanthoma Type

Keratoacanthoma has been described as a benign lesion that spontaneously involutes and as a variant of squamous cell carcinoma that rarely can behave aggressively. We present a case of a keratoacanthoma-like lesion in an elderly patient that recurs invading deeply into vital structures.

Diagnosis

The diagnosis of a classic keratoacanthoma (KA) is based on clinical and histologic findings. Clinically, the classic KA appears as a nodule with a central keratin-filled crater. It has three phases of behavior:


(1) a proliferative phase of 2–10 weeks,
(2) a stationary period of 2-10 weeks, and
(3) an involution phase of up to one year duration.

 

KA has distinct histological features of keratin-filled crater lined by a proliferating squamous epithelium. Shave or incisional punch biopsies are usually inadequate to diagnose keratoacanthoma, and the definite diagnosis can only be established after tumor excision, based on the histological findings.

Treatment

Treatment of classic keratoacanthomas can be conservative given their self-limiting course and has included curettage and intralesional methotrexate.

 

The catch with KA is the association with squamous cell carcinoma (SCC) and occasional aggressive behavior. 16.7% of KA are SCC. This speaks to the significant overlap in the clinical and histological appearance of the two, which can result in misdiagnosis of SCC as KA. In addition, KA may coexist with a SCC in the same lesion, as the more aggressive cell line eventually transforms the tumor into an aggressive lesion. The development of SCC in a KA has been reported in 5.7% of KA’s. In patients older than 90 years, the transformation incidence was found to be almost 14%.

 

Metastases with KA’s are very rare even with evidence of perineural invasion. It has been suggested that perineural invasion in KA’s is less significant than in SCC.

 

Treatment of keratoacanthomas is surgery. Mohs surgery is the standard with a reported recurrence rate of 2.4%. Radiation including orthovoltage has been shown to be highly effective as well.

 

Read case study here.

 

References:
Petrie, et al. Keratoacanthoma of the Head and Neck with Perineural Invasion. Dermatol Surg 2010; 36:7: 1209-1213
Donohue, et al. Treatment of aggressive keratoacanthomas by radiotherapy. J Am Acad Dermatol 1990; 23:3: 489-493.
Larson. Keratoacanthomas treated with Mohs’ micrographic surgery. J Am Acad Dermatol 1987; 16:5: 1040-1044.
Caccialanza, et al. Radiation therapy of keratoacanthomas: results in 55 patients. Int J of Radiat Oncol Biol Phys 1989; 16:2: 475-477.
Mandrell, et al. Keratoacanthoma: hyperplasia, benign neoplasm, or a type of squamous cell carcinoma? Semin in Diagnost Pathol 2009; 26:3: 150-163.
Donaldson, et al. Periocular keratoacanthoma. Ophthalmology 2003; 110:7: 1403-1407.

recurrent-bowens-disease-squamous-cell-carcinoma-topical-chemotherapy
Recurrent Bowen’s Disease of Temple
HISTORY 63-year-old man presents with 9-month history of Bowen’s disease of right anterior and posterior sideburn biopsied on 08-20-18. History of previous Mohs excision of Bowen’s disease of the same area in February 2016. Patient has a history of multiple basal cell carcinomas, squamous cell carcinomas, and melanoma. DISCUSSION Management of this lesion is best…
Read More
cystic-squamous-cell-carcinoma-of-forearm-keratoacanthoma-dermatopathology
Cystic Squamous Cell Carcinoma of Forearm Skin
HISTORY 74-year-old man presents with 3-month history of painful lesion of the right forearm.  Biopsy found cystic squamous cell carcinoma with deep margins involved. Wide local excision was performed achieving clear margins. DISCUSSION Cystic degeneration within squamous cell carcinoma of the skin is not considered an especially malignant finding. These histologic findings may represent changes…
Read More
anticoagulant-use-in-cutaneous-surgery-scalp-squamous-cell-carcinoma-Mohs-and-reconstruction
Anticoagulant Use in Cutaneous Surgery
HISTORY 87-year-old man with atrial fibrillation presented with squamous cell carcinoma in situ of scalp and forehead. Patient was treated with Mohs and reconstruction on 7-3-18. Incisional hematomas appeared 2.5 weeks post Mohs and treated with I&D. Patient continued warfarin and baby aspirin throughout treatments. DISCUSSION Anticoagulant use in Facial and Dermatologic Surgeries has become…
Read More
Recurrent-SCC-nose-rhinectcomy-mapping-biopsy-SCARS-center-Mohs-excision-infiltrative-squamous-cell
Recurrent SCC of Nasal Tip
HISTORY 71-year-old man presents with recurrence of SCC of nose following Mohs excision on 2-9-17. Partial rhinectomy was performed with incomplete Mohs excision leaving residual positive margins due to patient’s comfort.  Two additional excisions of involved margins were done under anesthesia achieving clear margins. First stage reconstruction was performed on 4-11-18. DISCUSSION Management of a…
Read More
SCC-Scalp-Newport-Beach-Mohs-and-Reconstruction-perineural-invasion
SCC of Scalp
HISTORY 86-year-old man presents with 3-month history of a mass in the left occipital scalp. 1 year prior, the patient underwent Mohs excision of a large scalp SCC.  FNA biopsy on 1-22-18 found atypical squamous cells. CT PET scan showed cancer limited to the mass itself with no lymph node enhancement. Patient experienced progressively increasing…
Read More
Dysplasia-lower-lip-actinic-cheilitis-skin-cancer-SCC
Dysplasia of Lower Lip
HISTORY 51-year-old man presents with one-year history of lower lip nonhealing lesion. The patient has a many year history of extensive sun exposure with scaling and crusting.  A biopsy of the nonhealing lesion showed leukokeratosis with minimal keratinocytic atypia. Excisional biopsy done 11-1-17 showed moderate to focally severe squamous atypia. The patient was then treated…
Read More

STAY UP TO DATE

Receive research updates, inspiring stories, healthy living tips and more.

Something went wrong. Please check your entries and try again.

FOLLOW US

ELEVATING THE STANDARDS OF SKIN CANCER MANAGEMENT.

© 2018 SCARS Management Services. All rights reserved.